<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gabrielle Schittecatte</style></author><author><style face="normal" font="default" size="100%">Marie Delnord</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Belgian Inventory of Cancer Care and Control Policies: a state of play for 2023</style></title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Belgian Cancer Inventory</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer Care</style></keyword><keyword><style  face="normal" font="default" size="100%">Cancer Control Policies</style></keyword><keyword><style  face="normal" font="default" size="100%">state of play</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year></dates><publisher><style face="normal" font="default" size="100%">Zenodo</style></publisher><pages><style face="normal" font="default" size="100%">75</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;This inventory compiles the latest publicly available data on the burden of cancer and cancer care control policies in Belgium, spanning prevention, early detection and screening, diagnosis, treatment, care organisation, quality of care and survivorship. It also details crosscutting topics such as patient centeredness and the reduction of inequalities in cancer care. Policies, including legal statues and mandates, that frame each part of cancer control activities, as well as the actors involved in each stage are also detailed in each of the inventory’s chapters. An analysis of gaps and needs was conducted for each of the thematic areas in cancer control. These analyses were based on a non-systematic review of grey and peer-reviewed literature, and were complimented by multi-stakeholder discussions with members of the Cancer Centre’s EBCP Belgian Mirror Groups (1).&lt;/p&gt;

&lt;p&gt;Download to read more&lt;/p&gt;
</style></abstract></record></records></xml>